FEBS Letters · 2002 · 29 citations · 21 references
Life SciencesMolecular BiologyOncologyCell SignalingGene ExpressionSignal TransductionCancer Cell SignalingMetastatic Signaling PathwaysMitogenic SignalingOncogenic Signaling PathwaysSignal Transduction In CancerBone Metastasis SignalingDominant Negative EffectsMapk SignalingMitogen-activated Protein Kinase SignalingSmad Signaling PathwaySmad-mediated Signal TransductionTranscriptional ActivationTransforming Growth Factor-beta Signaling
Transforming growth factor (TGF)-beta1, a crucial molecule in metastatic bone cancer, stimulates collagenase-3 expression in the human breast cancer cell line, MDA-MB231. Cycloheximide inhibited this stimulation, indicating that de novo protein synthesis was essential for this response. We examined whether mitogen-activated protein kinase (MAPK) and/or Smad pathways are involved in TGF-beta1-stimulated collagenase-3 expression in MDA-MB231 cells. Biochemical blockade of extracellular regulated kinase-1/2 and p38 MAPK pathways partially abolished TGF-beta1-stimulated collagenase-3 mRNA expression; whereas overexpression of a dominant negative form of Smad3 completely blocked the TGF-beta1-response. These data indicate that TGF-beta1-induced MAPK and Smad pathways are involved in TGF-beta1-stimulated collagenase-3 expression in MDA-MB231 cells.
21
Regulation of matrix metalloproteinase expression in tumor invasion
Jukka Westermarck, Veli‐Matti Kähäri · The FASEB Journal · 1999 · 1.5K citations
Medicine, Cancer Biology, Oncology +17